Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NFkappaB and Bcl-X L

Investigational New Drugs
Jae Hong SeoJun Suk Kim

Abstract

Arginine deiminase (ADI) is known to be an inducer of apoptosis in vitro and an anti-tumor agent in vivo in some cancers. ADI causes the enzymatic depletion of arginine which may inhibit nitric oxide (NO) synthesis. However, the effect of ADI treatment on NO synthesis has not been clearly elucidated. With the goal of understanding the role of ADI in NO synthesis, we used the Ramos human lymphoma cell line, which is known to be ADI-sensitive. After determining an optimal experimental ADI concentration (0.001 U/ml), we studied the effects of ADI treatment when combined with different concentrations of the extrinsic NO donor, sodium nitroprusside (SNP) (i.e., control, ADI only, ADI with 10 microM/ml SNP, ADI with 50 microM/ml SNP, and ADI with 100 microM/ml SNP). An MTT assay was used to assess cell survival after treatment, nitric oxide assays to determine nitrite levels and Western blot analysis to determine the expression of the NO mediators, NFkappaB and Bcl-X L. Interestingly, we found that the extrinsic NO donor only partially reversed ADI-induced inhibition of cell growth in a dose-dependent pattern and resulted in an induction of NFkappaB and Bcl-X L expression. In conclusion, we suggest that there might be an association ...Continue Reading

References

May 8, 1992·International Journal of Cancer. Journal International Du Cancer·H TakakuK Miyazaki
Sep 1, 1995·Japanese Journal of Cancer Research : Gann·H TakakuK Miyazaki
Jan 1, 1995·Advances in Pharmacology·J M GriscavageL J Ignarro
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·P J MorinK W Kinzler
Jan 1, 1997·Experimental Parasitology·L A KnodlerM R Edwards
Feb 1, 1997·International Journal of Hematology·Y KomadaE Azuma
Jul 16, 1999·Biochemical and Biophysical Research Communications·H GongL Schweigerer
Apr 20, 2000·Journal of Cellular Biochemistry·F DoddC K Too
Sep 7, 2000·Biochemical and Biophysical Research Communications·M Mori, T Gotoh
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·K L DavisF Murad
Jul 21, 2001·The Biochemical Journal·W K AldertonR G Knowles
Jun 18, 2002·Cancer Letters·Karin BeloussowWei Chiang Shen
Jul 17, 2003·International Journal of Cancer. Journal International Du Cancer·Uwe WenzelHannelore Daniel

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis